Skip to main content
. 2012 Jun;40(6):1198–1209. doi: 10.1124/dmd.112.045088

TABLE 1.

Primer sequences for validation of novel transcripts identified by RNA-Seq

Gene Method Amplification Direction Sequence (5′ to 3′) PCR Product
bp
Cyp2b10 Endpoint PCR From exon 6 to exon 9 (including cassette exon) Forward ATGGCTTCCTGCTCATGCTCAAGT 411
Reverse GACAAATGCGCTTTCCCACAGACT
Sequencing From exon 7 to exon 9 AGTGCCACACAGAGTGACCAAAGA
Cyp2d26 Endpoint PCR From exon 5 to cassette exon Forward ACTACACATCCCTGGTTTGCCTGA 520
Reverse AGCCTCTGAGCACCTTCTCTTGTA
Sequencing From exon 6 to cassette exon TGATTGACCTGTTCATGGCAGGGA
Endpoint PCR From cassette exon to exon 9 Forward TACAAGAGAAGGTGCTCAGAGGCT 327
Reverse TAGGGCTCTGGAGTAACTGGCATT
Sequencing From exon 8 to cassette exon CATGAAGGCCTCGTGCTTCACAAA
Cyp3a13 3′-RACE cDNA synthesis GCGAGCACAGAATTAATACGACTCACTATAGGT12VN
Outer PCR Forward AAGTTGCTCTTGTCAGAGTCCTGC
Reverse GCGAGCACAGAATTAATACGACT
Inner PCR Forward CACTGTCCAGCCTTGTAAGGAAAC
Reverse CGCGGATCCGAATTAATACGACTCACTATAGG
Sequencing AAGTTGCTCTTGTCAGAGTCCTGC